Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand D08

ORGANOPlus Co., Ltd.

About Us

AI Platform for Novel Strain Discovery and Functional Evaluation using Organ-on-a-Chip Technology. Microbiome-based drug (LBP) development, therapeutics/antibiotics, health functional foods, and cosmetic ingredient development

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Other
Contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand D08

Products Featured at CPHI South East Asia 2026

  • VILLIORGAN

    Product VILLIORGAN

    This is a Gut-on-a-chip validation platform that biomimetically recapitulates the human intestinal villi, mucin layer, barrier function, and gut microbiota environment. Utilizing a 3D villi-shaped membrane structure, it establishes a co-culture environment with anaerobic microbes.